Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
TMO stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Thermo Fisher Scientific Inc stock logo

Thermo Fisher Scientific Inc

TMO·NYSE

Last updated as of 2026-02-27 04:10 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

TMO stock price change

On the last trading day, TMO stock closed at 513.68 USD, with a price change of -0.37% for the day.
Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

TMO key data

Previous close513.68 USD
Market cap192.99B USD
Volume1.48M
P/E ratio28.96
Dividend yield (TTM)0.33%
Dividend amount0.43 USD
Last ex-dividend dateDec 15, 2025
Last payment dateJan 15, 2026
EPS diluted (TTM)17.74 USD
Net income (FY)6.74B USD
Revenue (FY)44.56B USD
Next report dateApr 29, 2026
EPS estimate5.270 USD
Revenue estimate10.86B USD USD
Shares float375.06M
Beta (1Y)0.83
Tokenized stocks

Have you heard of stock tokens?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Thermo Fisher Scientific Inc overview

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.
Sector
Health technology
Industry
Medical Specialties
CEO
Marc N. Casper
Headquarters
Waltham
Website
thermofisher.com
Founded
1956
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-

TMO Pulse

Daily updates on TMO stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• TMO Stock Price 24h change: -0.30%. From 515.60 USD to 514.20 USD. The slight decline followed a period of insider selling and a "Strong Sell" technical outlook, despite a recent earnings beat and a 10% dividend hike.
• From a technical perspective, the stock is currently in a "Strong Sell" phase with short-term and medium-term moving averages (50-day SMA at $576.02) trending below long-term levels. The 14-day RSI stands at 51.89, indicating a neutral momentum as the market digests recent volatility and tests support levels near the $514 mark.
• Thermo Fisher's Board authorized a new $5.0 billion share buyback program and increased its quarterly cash dividend by 10% to $0.47 per share, signaling confidence in long-term cash flow despite recent stock price pressure.
• Institutional activity shows a mixed sentiment; while Citizens Business Bank increased its stake by 79.9%, major firms like Primecap Management and Mitsubishi UFJ reduced their positions in the most recent quarter.
• Recent filings reveal significant insider selling, with executives disposing of approximately 98,271 shares valued at $56.92 million over the past three months, which has contributed to cautious investor sentiment.
• The 2026 Life Sciences Outlook indicates over 75% of sector executives are confident in their financial outlooks, driven by AI-enabled drug discovery and a rebound in M&A activity despite global economic uncertainty.
• New regulatory trends, including the potential implementation of international reference pricing in the U.S., are emerging as the single largest pricing disruption facing the global pharmaceutical and life sciences tools industry.
See more
about 17h ago
• TMO Stock Price 24h change: +0.37%. From 515.60 USD to 517.50 USD. The slight uptick followed a period of downward pressure, as the market balances a recent earnings beat against broader sector caution and insider selling activity.
• From a technical perspective, TMO exhibits a "bearish short-term momentum within a long-term recovery": while the 200-day moving average (~505.42) provides a "Buy" signal and support, the 50-day average (~579.30) suggests a "Sell" signal. The RSI at 28.3 indicates the stock is currently in oversold territory, potentially nearing a rebound point.
• Thermo Fisher recently entered a strategic data collaboration with Datavant to link real-world healthcare data with clinical research, aiming to accelerate study designs and patient recruitment.
• Executive Vice President Gianluca Pettiti sold 400 shares on February 9th at an average price of $541.20, continuing a trend of minor insider divestments over the last 90 days.
• Management reiterated a mid-single-digit organic growth forecast for 2026, supported by strong Q4 earnings where EPS of $6.57 beat consensus estimates of $6.45.
• A coalition of 15 U.S. states filed a lawsuit against the CDC regarding recent vaccine policy changes, signaling potential regulatory shifts that could impact the broader biopharma supply chain.
• Industry reports highlight a significant 85.83% drop in global pharma and healthcare funding in early 2026, reflecting a more cautious investment environment despite steady demand for specialized medical technology.
See more
about 1D ago

TMO stock price forecast

According to technical indicators for TMO stock, the price is likely to fluctuate within the range of 603.54–653.07 USD over the next week. Market analysts predict that the price of TMO stock will likely fluctuate within the range of 417.13–720.84 USD over the next months.

Based on 1-year price forecasts from 89 analysts, the highest estimate is 1114.35 USD, while the lowest estimate is 427.81 USD.

For more information, please see the TMO stock price forecast page.

Latest TMO stock news

What Can You Anticipate From Mettler-Toledo’s (MTD) Fourth Quarter Earnings

101 finance2026-02-04 03:21:38

Illumina (ILMN) Q4 Preview: Key Insights Before Earnings Release

101 finance2026-02-04 03:30:32

Kulicke and Soffa (NASDAQ:KLIC) Surpasses Forecasts with Robust Q4 Performance, Though Inventory Rises

101 finance2026-02-04 22:18:31

5 Thought-Provoking Analyst Inquiries from Thermo Fisher’s Fourth Quarter Earnings Discussion

101 finance2026-02-05 10:21:31

IQVIA forecasts weak annual profit on higher interest expenses

101 finance2026-02-05 14:12:36

OpenAI introduces the Frontier platform for AI agents, causing software stocks to decline

101 finance2026-02-05 16:24:11

Daniel Loeb's Third Point Loads Up On Chipotle, Constellation, Alibaba While Slashing TSM, Amazon in Q4 Shake-Up

Finviz2026-02-18 07:30:37

Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair

Finviz2026-02-23 13:15:45

Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast

Finviz2026-02-24 19:33:05

Thermo Fisher’s Surprising Drop: Understanding the Stock Decline After Beating Estimates

101 finance2026-02-25 15:51:59

Thermo Fisher’s Dividend Hike Defies 0.37% Drop as $0.76 Billion Volume Ranks 161st

101 finance2026-02-25 23:15:53

Waters Shares Slide 2.1% as Earnings Beat Outshine 406th-Ranked Volume Dips

101 finance2026-02-26 00:27:49

Trane Technologies (TT) Powers Growth with Data Center Cooling

Finviz2026-02-26 14:36:43

Thermo Fisher (TMO) Rises on 1.25% Gains as $0.8B Volume Ranks 167th with Dividend Hike and Buyback Fueling Momentum

101 finance2026-02-26 23:15:59

Thermo Fisher's Q4: A Beat, But the Guidance Reset the Expectation Gap

101 finance2026-02-27 05:18:43

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Thermo Fisher Scientific Inc?

TMO is currently priced at 513.68 USD — its price has changed by -0.37% over the past 24 hours. You can track the stock price performance of Thermo Fisher Scientific Inc more closely on the price chart at the top of this page.

What is the stock ticker of Thermo Fisher Scientific Inc?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Thermo Fisher Scientific Inc is traded under the ticker TMO.

What is the stock forecast of TMO?

We've gathered analysts' opinions on Thermo Fisher Scientific Inc's future price. According to their forecasts, TMO has a maximum estimate of 5136.80 USD and a minimum estimate of 1027.36 USD.

What is the market cap of Thermo Fisher Scientific Inc?

Thermo Fisher Scientific Inc has a market capitalization of 192.99B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock token prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Stock token perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially stock token perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
TMO